Clinical diagnostics companies are rushing to unlock the power of genomics to deliver on the promise of precision medicine. However the volume of genomic data presents scalability, reliability, and compliance challenges for next-generation sequencing data analysis systems. The massive size and scope of data, the effort involved to develop and operate production analysis pipelines at scale, and the need to operate in a clinically compliant environment place a heavy burden on existing IT infrastructure. In a business where turnaround time and consistency mean everything, these challenges can limit future growth.